Literature DB >> 8980710

The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat.

A B DeAngelo1, F B Daniel, B M Most, G R Olson.   

Abstract

The chlorinated acetic acids, in particular dichloroacetic acid (DCA), are found as chlorine disinfection by-products in finished drinking water supplies. DCA has previously been demonstrated to be a mouse liver carcinogen. Chronic studies are described in which male Fischer (F344) rats were exposed to DCA in their drinking water. In the first study, 28 day old rats were exposed to a regimen of 0.05, 0.5 and 5.0 g/l DCA. When animals in the high dose group began to exhibit peripheral hind leg neuropathy, the dose was lowered in stages to 1 g/l. These animals were sacrificed at 60 weeks due to the severe, irreversible neuropathy and were not included in this analysis. The remaining groups of animals were treated for 100 weeks. In the second study, rats were initially exposed to 2.5 g/l DCA which was lowered to 1 g/l after 18 weeks. The mean daily concentration (MDC) of 1.6 g/l was calculated over the 103 week exposure period. Time-weighted mean daily doses (MDD) based on measured water consumption were 3.6, 40.2 and 139 mg/kg bw/day for the 0.05, 0.5 and 1.6 g/l DCA respectively. Based upon the pathologic examination, DCA induced observable signs of toxicity in the nervous system, liver and myocardium. However, treatment related neoplastic lesions were observed only in the liver. A statistically significant increase of carcinogenicity (hepatocellular carcinoma) was noted at 1.6 g/l DCA. Exposure to 0.5 g/l DCA increased-hepatocellular neoplasia, (carcinoma and adenoma) at 100 weeks. These data demonstrate that DCA is an hepatocarcinogen to the male F344 rat. Calculation of the MDD at which 50% of the animals exhibited liver neoplasia indicated that the F344 male rat (approximately 10 mg/kg bw/day) is ten times more sensitive than the B6C3F1 male mouse (approximately 100 mg/kg bw/day). A "no observed effects level' (NOEL) of 0.05 g/l (3.6 mg/kg/day) was the same as for the mouse (3-8 mg/kg/day).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8980710     DOI: 10.1016/s0300-483x(96)03510-x

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  21 in total

1.  Effects of chlorinated acetates on the glutathione metabolism and on glycolysis of cultured astrocytes.

Authors:  Maike M Schmidt; Astrid Rohwedder; Ralf Dringen
Journal:  Neurotox Res       Date:  2010-07-14       Impact factor: 3.911

2.  The toxic influence of dibromoacetic acid on the hippocampus and pre-frontal cortex of rat: involvement of neuroinflammation response and oxidative stress.

Authors:  Wenbo Jiang; Bai Li; Yingying Chen; Shuying Gao
Journal:  Metab Brain Dis       Date:  2017-08-26       Impact factor: 3.584

3.  F344/NTac Rats Chronically Exposed to Bromodichloroacetic Acid Develop Mammary Adenocarcinomas With Mixed Luminal/Basal Phenotype and Tgfβ Dysregulation.

Authors:  J B Harvey; H-H L Hong; S Bhusari; T-V Ton; Y Wang; J F Foley; S D Peddada; M Hooth; M DeVito; A Nyska; A R Pandiri; M J Hoenerhoff
Journal:  Vet Pathol       Date:  2015-03-02       Impact factor: 2.221

4.  Toxicity and carcinogenicity of the water disinfection byproduct, dibromoacetic acid, in rats and mice.

Authors:  Ronald L Melnick; Abraham Nyska; Paul M Foster; Joseph H Roycroft; Grace E Kissling
Journal:  Toxicology       Date:  2006-12-08       Impact factor: 4.221

5.  Glutathione transferase zeta catalyses the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid.

Authors:  Z Tong; P G Board; M W Anders
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

6.  Mice deficient in glutathione transferase zeta/maleylacetoacetate isomerase exhibit a range of pathological changes and elevated expression of alpha, mu, and pi class glutathione transferases.

Authors:  Cindy E L Lim; Klaus I Matthaei; Anneke C Blackburn; Richard P Davis; Jane E Dahlstrom; Mark E Koina; M W Anders; Philip G Board
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

7.  Clarification of the role of key active site residues of glutathione transferase zeta/maleylacetoacetate isomerase by a new spectrophotometric technique.

Authors:  Philip G Board; Matthew C Taylor; Marjorie Coggan; Michael W Parker; Hoffman B Lantum; M W Anders
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

8.  Effects of Multiple Doses of Dichloroacetate on GSTZ1 Expression and Activity in Liver and Extrahepatic Tissues of Young and Adult Rats.

Authors:  Edwin J Squirewell; Marci G Smeltz; Laura Rowland-Faux; Lloyd P Horne; Peter W Stacpoole; Margaret O James
Journal:  Drug Metab Dispos       Date:  2020-09-01       Impact factor: 3.922

9.  Peripheral neuropathy in rats exposed to dichloroacetate.

Authors:  Nigel A Calcutt; Veronica L Lopez; Arjel D Bautista; Leah M Mizisin; Brenda R Torres; Albert L Shroads; Andrew P Mizisin; Peter W Stacpoole
Journal:  J Neuropathol Exp Neurol       Date:  2009-09       Impact factor: 3.685

10.  Evaluation of dichloroacetic acid for carcinogenicity in genetically modified Tg.AC hemizygous and p53 haploinsufficient mice.

Authors:  Grace E Kissling; David E Malarkey; Molly K Vallant; Jerry D Johnson; Milton R Hejtmancik; Ronald A Herbert; Gary A Boorman
Journal:  Toxicol Sci       Date:  2008-10-30       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.